#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Soft tissue necrosis Testicular leiomyosarcoma Chronic hepatitis B Marginal zone lymphoma refractory Richter's syndrome Ocular myasthenia Myxofibrosarcoma Chronic graft versus host disease Follicular lymphoma stage III Neovascular age-related macular degeneration Salivary gland cancer Brain stem glioma Waldenstrom's macroglobulinaemia refractory Mucous membrane pemphigoid Chondrosarcoma metastatic More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Diagnostics Wiskott-Aldrich syndrome – Basic Information Paroxysmal nocturnal haemoglobinuria – Diagnostics Stevens-Johnson syndrome – Trials in Disease Indolent systemic mastocytosis Malignant fibrous histiocytoma – Trials in Disease Hereditary neuropathic amyloidosis Noonan syndrome Mast cell activation syndrome – Treatment Primary mediastinal large B-cell lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ulipristal Acetate Amlodipine Besilate Progesterone Ph. Eur. Ibutamoren Mesilate Lenzumestrocel Nepafenac POTASSIUM HYDROXIDE Vinblastine Sulfate Fusidic Acid Trospium Chloride COLESEVELAM HYDROCHLORIDE Valsartan Mk-0482 Roxadustat Selpercatinib Inupadenant Rupatadine Formoterol Fumarate Dihydrate Alisertib Sodium PICLIDENOSON More therapies…

    Learn about Your Condition

    Rhabdomyosarcoma recurrent B-cell type acute leukaemia Muscle strain Arrhythmia Oesophageal food impaction Crohn's disease Corneal graft rejection Gallbladder cancer Medulloblastoma recurrent Ophthalmoplegia Glomerulonephritis chronic Penile cancer Radiation skin injury Ocular hypertension Fibrous dysplasia of bone More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Stopping Antibiotics in Adults with Viral Respiratory Infections Using Tetracyclines and Other Antibiotics

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory tract infection viral
    Norway

  • Study on Stiripentol for Patients Aged 6 and Older with Primary Hyperoxaluria Types 1, 2, or 3

    Recruiting

    3 1 1
    Investigated Drugs:
    • Stiripentol
    Belgium France Italy

  • Study on the Safety and Effects of CC-92480 with Dexamethasone and Drug Combinations for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • 2-(3-(3,5-Dimethyltriazol-4-Yl)-5-((S)-Oxan-4-Yl(Phenyl)Methyl)Pyrido(3,2-B)Indol-7-Yl)Propan-2-Ol
    • Tazemetostat
    • Mezigdomide
    Norway Spain

  • Study on the Effects of OATD-01 for Patients with Active Pulmonary Sarcoidosis

    Recruiting

    2 1
    Investigated Drugs:
    • 5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methylmorpholino)Piperidin-1-Yl)-1H- 1,2,4-Triazol-3-Amine
    Denmark France Germany Greece The Netherlands Norway

  • Study on Dual Antiplatelet Therapy Duration for Patients with Chronic Coronary Artery Blockage Using Clopidogrel and D,L-Lysine Acetylsalicylate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Clopidogrel
    • D,L-Lysine Acetylsalicylate
    France

  • Study on Personalized Treatment for Metastatic Colorectal Cancer Using Methotrexate and Drug Combination for Patients with Advanced Disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Panobinostat
    • Idelalisib
    • Binimetinib
    Norway
Previous Page
1 … 484 485 486 487 488 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!